These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 8239758
1. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis. Lau CS, McLaren M, Hanslip J, Kerr M, Belch JJ. Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758 [Abstract] [Full Text] [Related]
2. Endothelial cell activation in cutaneous vasculitis. Jurd KM, Stephens CJ, Black MM, Hunt BJ. Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765 [Abstract] [Full Text] [Related]
4. Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity. Li Y, Chen H, Tan J, Wang X, Liang H, Sun X. Eur J Clin Invest; 1998 Dec; 28(12):1050-4. PubMed ID: 9893018 [Abstract] [Full Text] [Related]
8. The fibrinolytic system in the hemolytic uremic syndrome: in vivo and in vitro studies. van de Kar NC, van Hinsbergh VW, Brommer EJ, Monnens LA. Pediatr Res; 1994 Aug; 36(2):257-64. PubMed ID: 7970942 [Abstract] [Full Text] [Related]
13. Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease. Sultan Y, Loyer F, Venot A. Nouv Rev Fr Hematol (1978); 1992 Aug; 34(1):55-60. PubMed ID: 1523100 [Abstract] [Full Text] [Related]
18. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system. Nicoloso G, Hauert J, Kruithof EK, Van Melle G, Bachmann F. Thromb Haemost; 1988 Apr 08; 59(2):299-303. PubMed ID: 3133812 [Abstract] [Full Text] [Related]